Engineered endolysin-based “artilysins” for controlling the gram-negative pathogen Helicobacter pylori

Overview of attention for article published in AMB Express, April 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 15 Dimensions

Readers on

mendeley: 40 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 15 publications that cite this research output.

15

The most recent citing publications are shown below. View all 15 publications that cite this research output on Dimensions.

Genetically Engineered Microorganisms and Their Impact on Human Health

Article in International Journal of Clinical Practice (March 2024)

Potential of antimicrobial peptide-fused endolysin LysC02 as therapeutics for infections and disinfectants for food contact surfaces to control Cronobacter sakazakii

Article in Food Control (March 2024)

The therapeutic effect of engineered phage, derived protein and enzymes against superbug bacteria

Article in Biotechnology and Bioengineering (October 2023)